Cargando…
Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy
Glioblastoma (GBM) is the most frequent and deadly primary brain tumor in adults. Temozolomide (TMZ) is the standard systemic therapy in GBM but has limited and restricted efficacy. Better treatments are urgently needed. The role of endoplasmic reticulum stress (ER stress) is increasingly described...
Autores principales: | Dowdell, Amiee, Marsland, Mark, Faulkner, Sam, Gedye, Craig, Lynam, James, Griffin, Cassandra P., Marsland, Joanne, Jiang, Chen Chen, Hondermarck, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158625/ https://www.ncbi.nlm.nih.gov/pubmed/37151848 http://dx.doi.org/10.1096/fba.2022-00141 |
Ejemplares similares
-
The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma
por: Marsland, Mark, et al.
Publicado: (2023) -
ProNGF Expression and Targeting in Glioblastoma Multiforme
por: Marsland, Mark, et al.
Publicado: (2023) -
Expression of NGF/proNGF and Their Receptors TrkA, p75(NTR) and Sortilin in Melanoma
por: Marsland, Mark, et al.
Publicado: (2022) -
The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer
por: Griffin, Nathan, et al.
Publicado: (2020) -
Postmortem brain donations vs premortem surgical resections for glioblastoma research: viewing the matter as a whole
por: Griffin, Cassandra P, et al.
Publicado: (2021)